{"abstracts-retrieval-response": {"item": {"ait:process-info": {"ait:status": {"@state": "update", "@type": "core", "@stage": "S300"}, "ait:date-delivered": {"@day": "06", "@timestamp": "2024-11-06T14:53:45.000045-05:00", "@year": "2024", "@month": "11"}, "ait:date-sort": {"@day": "01", "@year": "2013", "@month": "12"}}, "xocs:meta": {"xocs:funding-list": {"@pui-match": "primary", "@has-funding-info": "1", "xocs:funding-addon-generated-timestamp": "2021-06-01T17:23:34.938Z", "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"}}, "bibrecord": {"head": {"author-group": [{"affiliation": {"city-group": "Pathumwan, 10330 Bangkok", "country": "Thailand", "address-part": "1873, Rama IV Road", "@afid": "60028190", "@country": "tha", "organization": [{"$": "Division of Rheumatology"}, {"$": "Department of Medicine"}, {"$": "Faculty of Medicine, Chulalongkorn University"}], "affiliation-id": {"@afid": "60028190", "@dptid": "113019942"}, "@dptid": "113019942"}, "author": [{"ce:given-name": "Manathip", "preferred-name": {"ce:given-name": "Manathip", "ce:initials": "M.", "ce:surname": "Osiri", "ce:indexed-name": "Osiri M."}, "@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Osiri", "@auid": "6701738522", "ce:indexed-name": "Osiri M."}]}, {"affiliation": {"city-group": "Bangkok", "country": "Thailand", "@afid": "60022183", "@country": "tha", "organization": [{"$": "Department of Nursing"}, {"$": "King Chulalongkorn Memorial Hospital"}, {"$": "Thai Red Cross Society"}], "affiliation-id": [{"@afid": "60022183", "@dptid": "104136211"}, {"@afid": "60031780"}], "@dptid": "104136211"}, "author": [{"ce:given-name": "Youwanuch", "preferred-name": {"ce:given-name": "Youwanuch", "ce:initials": "Y.", "ce:surname": "Sattayasomboon", "ce:indexed-name": "Sattayasomboon Y."}, "@seq": "2", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Sattayasomboon", "@auid": "55774940800", "ce:indexed-name": "Sattayasomboon Y."}]}], "citation-title": "Prevalence and out-patient medical costs of comorbid conditions in patients with rheumatoid arthritis", "abstracts": "Objectives: To evaluate the prevalence, types, and out-patient direct medical costs of comorbid conditions in patients with RA in Thailand. Methods: Information of the patients with RA treated by rheumatologists with at least one disease modifying antirheumatic drugs (DMARDs), including demographic data, RA-related medication types and treatment costs, comorbidity-related medication types and treatment costs, and total direct medical costs, was captured from King Chulalongkorn Memorial Hospital databases. Results: The data from 684 patients with RA were included for analysis. The majority of the patients were prescribed combined DMARDs, while only 2.5% received biologics. Comorbid conditions were reported in 434 patients (63.5%). The most common comorbid condition was hypertension (51.2%). Advanced age and presence of healthcare coverage was associated with comorbid conditions. The average annual cost of non-RA-related treatments in patients with comorbid diseases was 15 times the cost in those without comorbidities (1546 vs. 104. USD; P< 0.001) while the total direct medical cost in patients with comorbid conditions was twice that in patients without comorbid diseases (4118 vs. 2045. USD; P< 0.001). Parameters that influenced total direct medical costs were RA medications costs, comorbidity, healthcare coverage, patient's age, and types of DMARDs. Conclusions: Comorbid conditions were common in this study. However, the major cost component incurred in RA patients was the costs of RA medications and services, while the out-patient costs of comorbid conditions accounted for approximately 38% of the total costs. \u00a9 2013 Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie.", "correspondence": {"affiliation": {"city-group": "Pathumwan, 10330 Bangkok", "country": "Thailand", "address-part": "1873, Rama IV Road", "@country": "tha", "organization": [{"$": "Division of Rheumatology"}, {"$": "Department of Medicine"}, {"$": "Faculty of Medicine, Chulalongkorn University"}]}, "person": {"ce:initials": "M.", "ce:surname": "Osiri", "ce:indexed-name": "Osiri M."}}, "citation-info": {"author-keywords": {"author-keyword": [{"$": "Comorbid condition", "@xml:lang": "eng"}, {"$": "Direct medical costs", "@xml:lang": "eng"}, {"$": "Disease modifying antirheumatic drugs", "@xml:lang": "eng"}, {"$": "Rheumatoid arthritis", "@xml:lang": "eng"}, {"$": "Societal perspective", "@xml:lang": "eng"}]}, "citation-type": {"@code": "ar"}, "citation-language": {"@language": "English", "@xml:lang": "eng"}, "abstract-language": {"@language": "English", "@xml:lang": "eng"}}, "source": {"codencode": "JBSPF", "sourcetitle-abbrev": "Jt. Bone Spine", "@country": "fra", "issn": [{"$": "1297319X", "@type": "print"}, {"$": "17787254", "@type": "electronic"}], "volisspag": {"voliss": {"@volume": "80", "@issue": "6"}, "pagerange": {"@first": "608", "@last": "612"}}, "@type": "j", "publicationyear": {"@first": "2013"}, "sourcetitle": "Joint Bone Spine", "@srcid": "12186", "publicationdate": {"month": "12", "year": "2013", "date-text": {"@xfab-added": "true", "$": "December 2013"}}}, "enhancement": {"classificationgroup": {"classifications": [{"@type": "EMCLASS", "classification": [{"classification-code": "17.3", "classification-description": "Public Health, Social Medicine and Epidemiology; HEALTH CARE"}, {"classification-code": "31.4.1", "classification-description": "Arthritis and Rheumatism; TREATMENT; Medical treatment"}, {"classification-code": "31.7.1", "classification-description": "Arthritis and Rheumatism; ARTHRITIS AND ARTHROSIS; Rheumatoid arthritis"}, {"classification-code": "36.2", "classification-description": "Health Policy, Economics and Management; HEALTH ECONOMICS"}, {"classification-code": "36.3.3", "classification-description": "Health Policy, Economics and Management; HEALTH CARE ORGANIZATION; Outpatient care"}, {"classification-code": "37", "classification-description": "Drug Literature Index"}]}, {"@type": "ASJC", "classification": "2745"}, {"@type": "SUBJABBR", "classification": "MEDI"}]}, "chemicalgroup": {"chemicals": {"@source": "esbd", "chemical": [{"cas-registry-number": "446-86-6", "chemical-name": "azathioprine"}, {"cas-registry-number": [{"$": "14092-94-5"}, {"$": "7440-70-2"}], "chemical-name": "calcium"}, {"cas-registry-number": [{"$": "132-73-0"}, {"$": "3545-67-3"}, {"$": "50-63-5"}, {"$": "54-05-7"}], "chemical-name": "chloroquine"}, {"cas-registry-number": [{"$": "59865-13-3"}, {"$": "63798-73-2"}], "chemical-name": "cyclosporin A"}, {"cas-registry-number": [{"$": "185243-69-0"}, {"$": "200013-86-1"}], "chemical-name": "etanercept"}, {"cas-registry-number": [{"$": "59-30-3"}, {"$": "6484-89-5"}], "chemical-name": "folic acid"}, {"cas-registry-number": [{"$": "118-42-3"}, {"$": "525-31-5"}], "chemical-name": "hydroxychloroquine"}, {"cas-registry-number": "170277-31-3", "chemical-name": "infliximab"}, {"cas-registry-number": "75706-12-6", "chemical-name": "leflunomide"}, {"cas-registry-number": [{"$": "15475-56-6"}, {"$": "59-05-2"}, {"$": "7413-34-5"}], "chemical-name": "methotrexate"}, {"cas-registry-number": "50-24-8", "chemical-name": "prednisolone"}, {"cas-registry-number": "174722-31-7", "chemical-name": "rituximab"}, {"cas-registry-number": "599-79-1", "chemical-name": "salazosulfapyridine"}]}}}}, "item-info": {"copyright": {"$": "Copyright 2013 Elsevier B.V., All rights reserved.", "@type": "Elsevier"}, "dbcollection": [{"$": "EMBASE"}, {"$": "NURSNG"}, {"$": "SCOPUS"}, {"$": "Scopusbase"}], "history": {"date-created": {"@day": "02", "@year": "2013", "@month": "07"}}, "itemidlist": {"itemid": [{"$": "52657726", "@idtype": "PUI"}, {"$": "2013754177", "@idtype": "EMBASE"}, {"$": "2013341202", "@idtype": "NURSNG"}, {"$": "84888440734", "@idtype": "SCP"}, {"$": "84888440734", "@idtype": "SGR"}, {"$": "603396083", "@idtype": "PUIsecondary"}, {"$": "634354651", "@idtype": "CAR-ID"}, {"$": "23827409", "@idtype": "MEDL"}], "ce:pii": "S1297319X13000468", "ce:doi": "10.1016/j.jbspin.2013.01.013"}}, "tail": {"bibliography": {"@refcount": "20", "reference": [{"ref-fulltext": "Gabriel S.E., Michaud K. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther 2009, 11:229.", "@id": "1", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases"}, "refd-itemidlist": {"itemid": {"$": "66249126493", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "11"}, "pagerange": {"@first": "229"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.E.", "@_fa": "true", "ce:surname": "Gabriel", "ce:indexed-name": "Gabriel S.E."}, {"@seq": "2", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Michaud", "ce:indexed-name": "Michaud K."}]}, "ref-sourcetitle": "Arthritis Res Ther"}}, {"ref-fulltext": "Osiri M., Maetzel A. The economic burden of rheumatoid arthritis: Asia/Thailand perspective. Handbook of disease burdens and quality of life measures 2010, 1733-1750. Springer Science+Business Media, New York. V.R. Preedy, R.R. Watson (Eds.).", "@id": "2", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "The economic burden of rheumatoid arthritis: Asia/Thailand perspective"}, "refd-itemidlist": {"itemid": {"$": "84886846348", "@idtype": "SGR"}}, "ref-volisspag": {"pagerange": {"@first": "1733", "@last": "1750"}}, "ref-text": "Springer Science+Business Media, New York, V.R. Preedy, R.R. Watson (Eds.)", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Osiri", "ce:indexed-name": "Osiri M."}, {"@seq": "2", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Maetzel", "ce:indexed-name": "Maetzel A."}]}, "ref-sourcetitle": "Handbook of disease burdens and quality of life measures"}}, {"ref-fulltext": "Kvien T.K. Epidemiology and burden of illness of rheumatoid arthritis. Pharmacoeconomics 2004, 22:1-12.", "@id": "3", "ref-info": {"ref-publicationyear": {"@first": "2004"}, "ref-title": {"ref-titletext": "Epidemiology and burden of illness of rheumatoid arthritis"}, "refd-itemidlist": {"itemid": {"$": "1442352158", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "22"}, "pagerange": {"@first": "1", "@last": "12"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "T.K.", "@_fa": "true", "ce:surname": "Kvien", "ce:indexed-name": "Kvien T.K."}]}, "ref-sourcetitle": "Pharmacoeconomics"}}, {"ref-fulltext": "Wolfe F. The burden of rheumatoid arthritis. Am J Manag Care 1999, 5:S852-S859.", "@id": "4", "ref-info": {"ref-publicationyear": {"@first": "1999"}, "ref-title": {"ref-titletext": "The burden of rheumatoid arthritis"}, "refd-itemidlist": {"itemid": {"$": "0032824473", "@idtype": "SGR"}}, "ref-volisspag": {"pages": "S852-S859", "voliss": {"@volume": "5"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Wolfe", "ce:indexed-name": "Wolfe F."}]}, "ref-sourcetitle": "Am J Manag Care"}}, {"ref-fulltext": "Lundkvist J., Kast\u00e4ng F., Kobelt G. The burden of rheumatoid arthritis and access to treatment: health burden and costs. Eur J Health Econ 2008, 8:S49-S60.", "@id": "5", "ref-info": {"ref-publicationyear": {"@first": "2008"}, "ref-title": {"ref-titletext": "The burden of rheumatoid arthritis and access to treatment: health burden and costs"}, "refd-itemidlist": {"itemid": {"$": "38449083553", "@idtype": "SGR"}}, "ref-volisspag": {"pages": "S49-S60", "voliss": {"@volume": "8"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Lundkvist", "ce:indexed-name": "Lundkvist J."}, {"@seq": "2", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Kast\u00e4ng", "ce:indexed-name": "Kastang F."}, {"@seq": "3", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Kobelt", "ce:indexed-name": "Kobelt G."}]}, "ref-sourcetitle": "Eur J Health Econ"}}, {"ref-fulltext": "Wolfe F., Mitchell D.M., Sibley J.T., et al. The mortality of rheumatoid arthritis. Arthritis Rheum 1994, 37:481-494.", "@id": "6", "ref-info": {"ref-publicationyear": {"@first": "1994"}, "ref-title": {"ref-titletext": "The mortality of rheumatoid arthritis"}, "refd-itemidlist": {"itemid": {"$": "0028328810", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "37"}, "pagerange": {"@first": "481", "@last": "494"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Wolfe", "ce:indexed-name": "Wolfe F."}, {"@seq": "2", "ce:initials": "D.M.", "@_fa": "true", "ce:surname": "Mitchell", "ce:indexed-name": "Mitchell D.M."}, {"@seq": "3", "ce:initials": "J.T.", "@_fa": "true", "ce:surname": "Sibley", "ce:indexed-name": "Sibley J.T."}], "et-al": null}, "ref-sourcetitle": "Arthritis Rheum"}}, {"ref-fulltext": "Symmons D.P., Jones M.A., Scott D.L., et al. Long-term mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well. J Rheumatol 1998, 25:1072-1077.", "@id": "7", "ref-info": {"ref-publicationyear": {"@first": "1998"}, "ref-title": {"ref-titletext": "Long-term mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well"}, "refd-itemidlist": {"itemid": {"$": "0031853541", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "25"}, "pagerange": {"@first": "1072", "@last": "1077"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "D.P.", "@_fa": "true", "ce:surname": "Symmons", "ce:indexed-name": "Symmons D.P."}, {"@seq": "2", "ce:initials": "M.A.", "@_fa": "true", "ce:surname": "Jones", "ce:indexed-name": "Jones M.A."}, {"@seq": "3", "ce:initials": "D.L.", "@_fa": "true", "ce:surname": "Scott", "ce:indexed-name": "Scott D.L."}], "et-al": null}, "ref-sourcetitle": "J Rheumatol"}}, {"ref-fulltext": "Michaud K., Wolfe F. Comorbidities in rheumatoid arthritis. Best Pract Res Clin Rheumatol 2007, 21:885-906.", "@id": "8", "ref-info": {"ref-publicationyear": {"@first": "2007"}, "ref-title": {"ref-titletext": "Comorbidities in rheumatoid arthritis"}, "refd-itemidlist": {"itemid": {"$": "34548510858", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "21"}, "pagerange": {"@first": "885", "@last": "906"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Michaud", "ce:indexed-name": "Michaud K."}, {"@seq": "2", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Wolfe", "ce:indexed-name": "Wolfe F."}]}, "ref-sourcetitle": "Best Pract Res Clin Rheumatol"}}, {"ref-fulltext": "Furst D.E., Chang H., Greenberg J.D., et al. Prevalence of low hemoglobin levels and associations with other disease parameters in rheumatoid arthritis patients: evidence from the CORRONA registry. Clin Exp Rheumatol 2009, 27:560-566.", "@id": "9", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "Prevalence of low hemoglobin levels and associations with other disease parameters in rheumatoid arthritis patients: evidence from the CORRONA registry"}, "refd-itemidlist": {"itemid": {"$": "70350179339", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "27"}, "pagerange": {"@first": "560", "@last": "566"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "D.E.", "@_fa": "true", "ce:surname": "Furst", "ce:indexed-name": "Furst D.E."}, {"@seq": "2", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Chang", "ce:indexed-name": "Chang H."}, {"@seq": "3", "ce:initials": "J.D.", "@_fa": "true", "ce:surname": "Greenberg", "ce:indexed-name": "Greenberg J.D."}], "et-al": null}, "ref-sourcetitle": "Clin Exp Rheumatol"}}, {"ref-fulltext": "Wolfe F., Michaud K., Li T., et al. Chronic conditions and health problems in rheumatic diseases: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, systemic lupus erythematosus, and fibromyalgia. J Rheumatol 2010, 37:305-315.", "@id": "10", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Chronic conditions and health problems in rheumatic diseases: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, systemic lupus erythematosus, and fibromyalgia"}, "refd-itemidlist": {"itemid": {"$": "76649125513", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "37"}, "pagerange": {"@first": "305", "@last": "315"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Wolfe", "ce:indexed-name": "Wolfe F."}, {"@seq": "2", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Michaud", "ce:indexed-name": "Michaud K."}, {"@seq": "3", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Li", "ce:indexed-name": "Li T."}], "et-al": null}, "ref-sourcetitle": "J Rheumatol"}}, {"ref-fulltext": "Berkanovic E., Hurwicz M.L. Rheumatoid arthritis and comorbidity. J Rheumatol 1990, 17:888-892.", "@id": "11", "ref-info": {"ref-publicationyear": {"@first": "1990"}, "ref-title": {"ref-titletext": "Rheumatoid arthritis and comorbidity"}, "refd-itemidlist": {"itemid": {"$": "0025371301", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "17"}, "pagerange": {"@first": "888", "@last": "892"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Berkanovic", "ce:indexed-name": "Berkanovic E."}, {"@seq": "2", "ce:initials": "M.L.", "@_fa": "true", "ce:surname": "Hurwicz", "ce:indexed-name": "Hurwicz M.L."}]}, "ref-sourcetitle": "J Rheumatol"}}, {"ref-fulltext": "Joyce A.T., Smith P., Khandker R., et al. Hidden cost of rheumatoid arthritis (RA): estimating cost of comorbid cardiovascular disease and depression among patients with RA. J Rheumatol 2009, 36:743-752.", "@id": "12", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "Hidden cost of rheumatoid arthritis (RA): estimating cost of comorbid cardiovascular disease and depression among patients with RA"}, "refd-itemidlist": {"itemid": {"$": "66149102390", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "36"}, "pagerange": {"@first": "743", "@last": "752"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.T.", "@_fa": "true", "ce:surname": "Joyce", "ce:indexed-name": "Joyce A.T."}, {"@seq": "2", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Smith", "ce:indexed-name": "Smith P."}, {"@seq": "3", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Khandker", "ce:indexed-name": "Khandker R."}], "et-al": null}, "ref-sourcetitle": "J Rheumatol"}}, {"ref-fulltext": "Kapetanovic M.C., Lindqvist E., Simonsson M., et al. Prevalence and predictive factors of comorbidity in rheumatoid arthritis patients monitored prospectively from disease onset up to 20years: lack of association between inflammation and cardiovascular disease. Scand J Rheumatol 2010, 39:353-359.", "@id": "13", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "Prevalence and predictive factors of comorbidity in rheumatoid arthritis patients monitored prospectively from disease onset up to 20years: lack of association between inflammation and cardiovascular disease"}, "refd-itemidlist": {"itemid": {"$": "77957966111", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "39"}, "pagerange": {"@first": "353", "@last": "359"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.C.", "@_fa": "true", "ce:surname": "Kapetanovic", "ce:indexed-name": "Kapetanovic M.C."}, {"@seq": "2", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Lindqvist", "ce:indexed-name": "Lindqvist E."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Simonsson", "ce:indexed-name": "Simonsson M."}], "et-al": null}, "ref-sourcetitle": "Scand J Rheumatol"}}, {"ref-fulltext": "Briggs A.M., March L., Lassere M., et al. Baseline comorbidities in a population-based cohort of rheumatoid arthritis patients receiving biological therapy: data from the Australian Rheumatology Association database. Int J Rheumatol 2009, 2009:861481.", "@id": "14", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "Baseline comorbidities in a population-based cohort of rheumatoid arthritis patients receiving biological therapy: data from the Australian Rheumatology Association database"}, "refd-itemidlist": {"itemid": {"$": "78751704268", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "2009"}, "pagerange": {"@first": "861481"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.M.", "@_fa": "true", "ce:surname": "Briggs", "ce:indexed-name": "Briggs A.M."}, {"@seq": "2", "ce:initials": "L.", "@_fa": "true", "ce:surname": "March", "ce:indexed-name": "March L."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Lassere", "ce:indexed-name": "Lassere M."}], "et-al": null}, "ref-sourcetitle": "Int J Rheumatol"}}, {"ref-fulltext": "Rupp I., Boshuizen H.C., Jacobi C.E., et al. Comorbidity in patients with rheumatoid arthritis: effect on health-related quality of life. J Rheumatol 2004, 31:58-65.", "@id": "15", "ref-info": {"ref-publicationyear": {"@first": "2004"}, "ref-title": {"ref-titletext": "Comorbidity in patients with rheumatoid arthritis: effect on health-related quality of life"}, "refd-itemidlist": {"itemid": {"$": "0346057905", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "31"}, "pagerange": {"@first": "58", "@last": "65"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "I.", "@_fa": "true", "ce:surname": "Rupp", "ce:indexed-name": "Rupp I."}, {"@seq": "2", "ce:initials": "H.C.", "@_fa": "true", "ce:surname": "Boshuizen", "ce:indexed-name": "Boshuizen H.C."}, {"@seq": "3", "ce:initials": "C.E.", "@_fa": "true", "ce:surname": "Jacobi", "ce:indexed-name": "Jacobi C.E."}], "et-al": null}, "ref-sourcetitle": "J Rheumatol"}}, {"ref-fulltext": "Heston A, Summers R, Aten B. Penn World Table Version 7.0. Center for International Comparisons of Production, Income and Prices at the University of Pennsylvania, May 2011.", "@id": "16", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "refd-itemidlist": {"itemid": {"$": "84888434200", "@idtype": "SGR"}}, "ref-text": "Penn World Table Version 7.0. Center for International Comparisons of Production, Income and Prices at the University of Pennsylvania, May", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Heston", "ce:indexed-name": "Heston A."}, {"@seq": "2", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Summers", "ce:indexed-name": "Summers R."}, {"@seq": "3", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Aten", "ce:indexed-name": "Aten B."}]}}}, {"ref-fulltext": "Thai Rheumatism Association Working Group Guideline for anti-TNF-\u03b1 therapies in rheumatoid arthritis. In: Guideline for anti-tumor necrosis factor-\u03b1 therapies in rheumatic diseases 2006, Thai Rheumatism Association, Bangkok, p.14-9 (in Thai language).", "@id": "17", "ref-info": {"ref-publicationyear": {"@first": "2006"}, "refd-itemidlist": {"itemid": {"$": "84888432818", "@idtype": "SGR"}}, "ref-text": "Thai Rheumatism Association Working Group, Thai Rheumatism Association, Bangkok, p.14-9 (in Thai language)", "ref-sourcetitle": "Guideline for anti-TNF-\u03b1 therapies in rheumatoid arthritis. In: Guideline for anti-tumor necrosis factor-\u03b1 therapies in rheumatic diseases"}}, {"ref-fulltext": "Wolfe F., Michaud K. Out-of-pocket expenses and their burden in patients with rheumatoid arthritis. Arthritis Rheum 2009, 61:1563-1570.", "@id": "18", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "Out-of-pocket expenses and their burden in patients with rheumatoid arthritis"}, "refd-itemidlist": {"itemid": {"$": "70449513694", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "61"}, "pagerange": {"@first": "1563", "@last": "1570"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Wolfe", "ce:indexed-name": "Wolfe F."}, {"@seq": "2", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Michaud", "ce:indexed-name": "Michaud K."}]}, "ref-sourcetitle": "Arthritis Rheum"}}, {"ref-fulltext": "Osiri M., Maetzel A., Tugwell P. The economic burden of rheumatoid arthritis in a developing nation: results from a one-year prospective cohort study in Thailand. J Rheumatol 2007, 34:57-63.", "@id": "19", "ref-info": {"ref-publicationyear": {"@first": "2007"}, "ref-title": {"ref-titletext": "The economic burden of rheumatoid arthritis in a developing nation: results from a one-year prospective cohort study in Thailand"}, "refd-itemidlist": {"itemid": {"$": "33846216464", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "34"}, "pagerange": {"@first": "57", "@last": "63"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Osiri", "ce:indexed-name": "Osiri M."}, {"@seq": "2", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Maetzel", "ce:indexed-name": "Maetzel A."}, {"@seq": "3", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Tugwell", "ce:indexed-name": "Tugwell P."}]}, "ref-sourcetitle": "J Rheumatol"}}, {"ref-fulltext": "Maravic M., Baudens G., Sanchez J.P., et al. rheumatoid arthritis: a medico-economic evaluation from 2008 French Hospital Database. Joint Bone Spine 2012, 79:96-97.", "@id": "20", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "Rheumatoid arthritis: a medico-economic evaluation from 2008 French Hospital Database"}, "refd-itemidlist": {"itemid": {"$": "84855687113", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "79"}, "pagerange": {"@first": "96", "@last": "97"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Maravic", "ce:indexed-name": "Maravic M."}, {"@seq": "2", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Baudens", "ce:indexed-name": "Baudens G."}, {"@seq": "3", "ce:initials": "J.P.", "@_fa": "true", "ce:surname": "Sanchez", "ce:indexed-name": "Sanchez J.P."}], "et-al": null}, "ref-sourcetitle": "Joint Bone Spine"}}]}}}}, "affiliation": [{"affiliation-city": "Bangkok", "@id": "60028190", "affilname": "Chulalongkorn University", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190", "affiliation-country": "Thailand"}, {"affiliation-city": "Bangkok", "@id": "60022183", "affilname": "King Chulalongkorn Memorial Hospital", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183", "affiliation-country": "Thailand"}], "coredata": {"srctype": "j", "eid": "2-s2.0-84888440734", "dc:description": "Objectives: To evaluate the prevalence, types, and out-patient direct medical costs of comorbid conditions in patients with RA in Thailand. Methods: Information of the patients with RA treated by rheumatologists with at least one disease modifying antirheumatic drugs (DMARDs), including demographic data, RA-related medication types and treatment costs, comorbidity-related medication types and treatment costs, and total direct medical costs, was captured from King Chulalongkorn Memorial Hospital databases. Results: The data from 684 patients with RA were included for analysis. The majority of the patients were prescribed combined DMARDs, while only 2.5% received biologics. Comorbid conditions were reported in 434 patients (63.5%). The most common comorbid condition was hypertension (51.2%). Advanced age and presence of healthcare coverage was associated with comorbid conditions. The average annual cost of non-RA-related treatments in patients with comorbid diseases was 15 times the cost in those without comorbidities (1546 vs. 104. USD; P< 0.001) while the total direct medical cost in patients with comorbid conditions was twice that in patients without comorbid diseases (4118 vs. 2045. USD; P< 0.001). Parameters that influenced total direct medical costs were RA medications costs, comorbidity, healthcare coverage, patient's age, and types of DMARDs. Conclusions: Comorbid conditions were common in this study. However, the major cost component incurred in RA patients was the costs of RA medications and services, while the out-patient costs of comorbid conditions accounted for approximately 38% of the total costs. \u00a9 2013 Soci\u00e9t\u00e9 fran\u00e7aise de rhumatologie.", "pubmed-id": "23827409", "prism:coverDate": "2013-12-01", "prism:aggregationType": "Journal", "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/84888440734", "dc:creator": {"author": [{"ce:given-name": "Manathip", "preferred-name": {"ce:given-name": "Manathip", "ce:initials": "M.", "ce:surname": "Osiri", "ce:indexed-name": "Osiri M."}, "@seq": "1", "ce:initials": "M.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Osiri", "@auid": "6701738522", "author-url": "https://api.elsevier.com/content/author/author_id/6701738522", "ce:indexed-name": "Osiri M."}]}, "link": [{"@_fa": "true", "@rel": "self", "@href": "https://api.elsevier.com/content/abstract/scopus_id/84888440734"}, {"@_fa": "true", "@rel": "scopus", "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84888440734&origin=inward"}, {"@_fa": "true", "@rel": "scopus-citedby", "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=84888440734&origin=inward"}], "source-id": "12186", "pii": "S1297319X13000468", "citedby-count": "20", "prism:volume": "80", "subtype": "ar", "dc:title": "Prevalence and out-patient medical costs of comorbid conditions in patients with rheumatoid arthritis", "openaccess": "0", "prism:issn": "1297319X 17787254", "prism:issueIdentifier": "6", "subtypeDescription": "Article", "prism:publicationName": "Joint Bone Spine", "prism:pageRange": "608-612", "prism:endingPage": "612", "openaccessFlag": "false", "prism:doi": "10.1016/j.jbspin.2013.01.013", "prism:startingPage": "608", "dc:identifier": "SCOPUS_ID:84888440734"}, "idxterms": {"mainterm": [{"$": "Adult", "@weight": "b", "@candidate": "n"}, {"$": "Aged", "@weight": "b", "@candidate": "n"}, {"$": "Ambulatory Care", "@weight": "b", "@candidate": "n"}, {"$": "Arthritis, Rheumatoid", "@weight": "b", "@candidate": "n"}, {"$": "Comorbidity", "@weight": "b", "@candidate": "n"}, {"$": "Female", "@weight": "b", "@candidate": "n"}, {"$": "Health Care Costs", "@weight": "b", "@candidate": "n"}, {"$": "Humans", "@weight": "b", "@candidate": "n"}, {"$": "Male", "@weight": "b", "@candidate": "n"}, {"$": "Middle Aged", "@weight": "b", "@candidate": "n"}, {"$": "Prevalence", "@weight": "b", "@candidate": "n"}, {"$": "Thailand", "@weight": "b", "@candidate": "n"}]}, "language": {"@xml:lang": "eng"}, "authkeywords": {"author-keyword": [{"@_fa": "true", "$": "Comorbid condition"}, {"@_fa": "true", "$": "Direct medical costs"}, {"@_fa": "true", "$": "Disease modifying antirheumatic drugs"}, {"@_fa": "true", "$": "Rheumatoid arthritis"}, {"@_fa": "true", "$": "Societal perspective"}]}, "subject-areas": {"subject-area": [{"@_fa": "true", "$": "Rheumatology", "@code": "2745", "@abbrev": "MEDI"}]}, "authors": {"author": [{"ce:given-name": "Manathip", "preferred-name": {"ce:given-name": "Manathip", "ce:initials": "M.", "ce:surname": "Osiri", "ce:indexed-name": "Osiri M."}, "@seq": "1", "ce:initials": "M.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Osiri", "@auid": "6701738522", "author-url": "https://api.elsevier.com/content/author/author_id/6701738522", "ce:indexed-name": "Osiri M."}, {"ce:given-name": "Youwanuch", "preferred-name": {"ce:given-name": "Youwanuch", "ce:initials": "Y.", "ce:surname": "Sattayasomboon", "ce:indexed-name": "Sattayasomboon Y."}, "@seq": "2", "ce:initials": "Y.", "@_fa": "true", "affiliation": {"@id": "60022183", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183"}, "ce:surname": "Sattayasomboon", "@auid": "55774940800", "author-url": "https://api.elsevier.com/content/author/author_id/55774940800", "ce:indexed-name": "Sattayasomboon Y."}]}}}